Deputy Prime Minister Tatyana Golikova told a government meeting Wednesday that 82.8 per cent of 301,500 hospital beds reserved for coronav...

Amid a spike in infections and deaths, Deputy Prime Minister Tatyana Golikova suggested introducing a nonworking period starting Oct 30 and...

The Kremlin described Russia's Covid fatality toll as "high" and the country's vaccination rate as "unacceptably" low, even as it rejected ...

The count included cases where the virus was not the main cause of death and where the virus was suspected but not confirmed.

Russia faced international criticism for approving a vaccine that hasn't completed advanced trials among tens of thousands of people, and e...

Sputnik V has been touted in Russia as the world's “first registered COVID-19 vaccine” after it received regulatory approval in early Augus...

The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia and tested among 100 volunteers in earl...

Russia on Tuesday became the first country to approve a coronavirus vaccine, a move that was met with international skepticism and unease b...

Earlier, Deputy Prime Minister Tatyana Golikova announced that mass production of the vaccine developed by the Gamaleya National Research C...

The drug developed by Moscow’s Gamaleya Institute and the Russian Direct Investment Fund may be approved for civilian use within three to s...

The U.S. is the largest source of financial support for the WHO, and its exit is expected to significantly weaken the organization. Trump s...

India, with a strong 48-member contingent, is among the 63 countries participating in the world's biggest international vocational skill co...

Russia last year recorded its highest birth rate in 25 years -- the government has announced, buoyed that its new policies aimed at reversi...